Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 3, 2020

Eleven isoquinoline alkaloids on inhibiting tissue factor activity: structure-activity relationships and molecular docking

  • Xuhua He , Yongjiang Zeng and Wenwen Jiang EMAIL logo

Abstract

Tissue factor (TF) which plays a key role in hemostasis and thrombosis appears to be an attractive target and medicinal plants having alkaloids inhibition TF activity benefit to cardiovascular disease (CVD). The aim of study is to explore further knowledge about alkaloids and TF. TF procoagulant activities were determined by the simplified chromogenic assay and their mRNA expression were then examined by reverse transcription and polymerase chain reaction. Besides, the potential of TF/FVIIa binding with four representative alkaloids were analyzed by molecular docking. The results indicated that these isoquinoline alkaloids with various structures had a different effect on suppression of TF activity. Molecular docking showed four alkaloids including l-corydalmine, berberine, jatrorrhizine, and tetrahydropalmatine were stably posed in the active binding pocket of TF/FVIIa. The SARs analysis showed the structural difference including planar, quaternary nitrogen, and the peripheral functional groups at C-8, C-9, C-10, have strong effect on inhibition of TF activity, which provided effective methods to modify isoquinoline alkaloids for inhibiting TF activity. This study provides a further evidence for the cardiovascular protection of isoquinoline alkaloids, and has physiological significance in the clinical challenge to use isoquinoline alkaloids or their potential analogs in the treatment of CVD.


Corresponding author: Wenwen Jiang, School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China, E-mail:
Xuhua He: Co-first author.

Funding source: Talent Introduction Project of Guizhou University of China

Award Identifier / Grant number: 2010039

Funding source: Science and Technology Project of Guizhou Province of China

Award Identifier / Grant number: [2019]1120

  1. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This study was supported by the Talent Introduction Project of Guizhou University of China (No.2010039) and the Science and Technology Project of Guizhou Province of China (No.[2019]1120).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Amin, S, Khan, H. Revival of natural products: utilization of modern technologies. Curr Bioact Compd 2016;12:103-6. https://doi.org/10.2174/1573407212666160314195845.Search in Google Scholar

2. Amirkia, V, Heinrich, M. Alkaloids as drug leads–a predictive structural and biodiversity-based analysis. Phytochem Lett 2014;10:xlviii-liii. https://doi.org/10.1016/j.phytol.2014.06.015.Search in Google Scholar

3. Luch, A. Molecular, clinical and environmental toxicology. In: Springer; 2009:20 p.10.1007/978-3-7643-8336-7Search in Google Scholar

4. Vasanthi, HR, ShriShriMal, N. Phytochemicals from plants to combat cardiovascular disease. Curr Med Chem 2012;19:2242–51. https://doi.org/10.2174/092986712800229078.Search in Google Scholar

5. Ain, QU, Khan, H, Mubarak, MS, Pervaiz, A. Plant alkaloids as antiplatelet agent: drugs of the future in the light of recent developments. Front Pharmacol 2016;7. https://doi.org/10.3389/fphar.2016.00292.Search in Google Scholar

6. Deaton, C, Froelicher, ES, Wu, LH, Ho, C, Shishani, K, Jaarsma, T. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs 2017;10:S5–13. https://doi.org/10.1016/s1474-5151(11)00111-3.Search in Google Scholar

7. Witkowski, M, Landmesser, U, Rauch, U. Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med 2016;26:297–303. https://doi.org/10.1016/j.tcm.2015.12.001.Search in Google Scholar

8. Rao, LVM, Pendurthi, UR. Regulation of tissue factor coagulant activity on cell surfaces. J Thromb Haemostasis 2012;10:2242–53. https://doi.org/10.1111/jth.12003.Search in Google Scholar

9. Mackman, N. Tissue-specific hemostasis in mice. Arterioscler Thromb Vasc Biol 2005;25:2273–81. https://doi.org/10.1161/01.atv.0000183884.06371.52.Search in Google Scholar

10. Grover, SP, Mackman, N. Tissue factor. Arterioscler Thromb Vasc Biol 2018;38:709–25. https://doi.org/10.1161/atvbaha.117.309846.Search in Google Scholar

11. Ge, HX, Zhang, J, Chen, L, Kou, JP, Yu, BY. Chemical and microbial semi-synthesis of tetrahydroprotoberberines as inhibitors on tissue factor procoagulant activity. Bioorg Med Chem 2013;21:62–9. https://doi.org/10.1016/j.bmc.2012.11.002.Search in Google Scholar

12. Gao, MY, Chen, L, Yang, L, Yu, X, Kou, JP, Yu, BY. Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-kappaB/p65, Akt and MAPK pathway in THP-1 cells. Pharmacol Rep 2014;66:480–4. https://doi.org/10.1016/j.pharep.2013.12.004.Search in Google Scholar

13. Semeraro, N, Ammollo, CT, Semeraro, F, Colucci, M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis 2010;2:2010024. https://doi.org/10.4084/mjhid.2010.024.Search in Google Scholar

14. Son, JK, Chang, H, Jahng, Y. Progress in studies on rutaecarpine. II.—synthesis and structure-biological activity relationships. Molecules 2015;20:10800–21. https://doi.org/10.3390/molecules200610800.Search in Google Scholar

15. Huang, Z, Zeng, Y, Lan, P, Sun, PH, Chen, WM. Advances in structural modifications and biological activities of berberine: an active compound in traditional Chinese medicine. Mini Rev Med Chem 2011;11:1122–9. https://doi.org/10.2174/138955711797655362.Search in Google Scholar

16. Wang, N, Świtalska, M, Wang, L, Shaban, E, Hossain, MI, Sayed, IETEl, et al. Structural modifications of nature-inspired indoloquinolines: a mini review of their potential antiproliferative activity. Molecules 2019;24:2121. https://doi.org/10.3390/molecules24112121.Search in Google Scholar

17. Zhang, Q, Chen, C, Wang, FQ, Li, CH, Zhang, QH, Hu, YJ, et al. Simultaneous screening and analysis of antiplatelet aggregation active alkaloids from Rhizoma Corydalis. Pharm Biol 2016;54:3113–20. https://doi.org/10.1080/13880209.2016.1211714.Search in Google Scholar

18. Safi, W, Kuehnl, A, Nussler, A, Eckstein, HH, Pelisek, J. Differentiation of human CD14+ monocytes: an experimental investigation of the optimal culture medium and evidence of a lack of differentiation along the endothelial line. Exp Mol Med 2016;48:e227. https://doi.org/10.1038/emm.2016.11.Search in Google Scholar

19. Oettel, A, Lorenz, M, Stangl, V, Costa, SD, Zenclussen, AC, Schumacher, A. Human umbilical vein endothelial cells foster conversion of CD4+CD25−Foxp3− T cells into CD4+Foxp3+ regulatory T cells via transforming growth factor-β. Sci Rep 2016;6:23278. https://doi.org/10.1038/srep23278.Search in Google Scholar

20. Jiang, W, Kou, JP, Yuan, ST, Sun, L, Yu, BY. A simplified and high-throughput chromogenic assay for testing tissue factor–dependent procoagulant activity. J Biomol Screen 2011;16:295–302. https://doi.org/10.1177/1087057110396370.Search in Google Scholar

21. Jiang, W, Kou, JP, Zhang, Z, Yu, BY. The effects of twelve representative flavonoids on tissue factor expression in human monocytes: structure-activity relationships. Thromb Res 2009;124:714–20. https://doi.org/10.1016/j.thromres.2009.04.010.Search in Google Scholar

22. Van Meerloo, J, Kaspers, GJL, Cloos, J. Cell sensitivity assays: the MTT assay. Methods Mol Biol 2011;731:237–45. https://doi.org/10.1007/978-1-61779-080-5_20.Search in Google Scholar

23. Rao, TP, Okamoto, T, Akita, N, Hayashi, T, Kato-Yasuda, N, Suzuki, K. Amla (Emblica officinalis Gaertn.) extract inhibits lipopolysaccharide-induced procoagulant and pro-inflammatory factors in cultured vascular endothelial cells. Br J Nutr 2013;110:2201–6.10.1017/S0007114513001669Search in Google Scholar PubMed

24. Morris, GM, Huey, R, Lindstrom, W, Sanner, MF, Belew, RK, Goodsell, DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91. https://doi.org/10.1002/jcc.21256.Search in Google Scholar

25. Lanka, G, Bathula, R, Bhargavi, M, Potlapally, SR. Homology modeling and molecular docking studies for the identification of novel potential therapeutics against human PHD3 as a drug target for type 2 diabetes mellitus. J Drug Deliv Therapeut 2019;9:265–73.Search in Google Scholar

26. Xiao, D, Liu, Z, Zhang, S, Zhou, M, He, F, Zou, M, et al. Berberine derivatives with different pharmacological activities via structural modifications. Mini Rev Med Chem 2018;18:1424–41. https://doi.org/10.2174/1389557517666170321103139.Search in Google Scholar

27. Jin, Y, Khadka, DB, Cho, WJ. Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin Ther Pat 2015;26:229–43. https://doi.org/10.1517/13543776.2016.1118060.Search in Google Scholar

28. Okubo, S, Uto, T, Goto, A, Tanaka, H, Nishioku, T, Yamada, K, et al. Berberine induces apoptotic cell death via activation of caspase-3 and -8 in hl-60 human leukemia cells: nuclear localization and structure-activity relationships. Am J Chin Med 2017;45:1497–511. https://doi.org/10.1142/s0192415x17500811.Search in Google Scholar

29. Li, ZC, Kong, XB, Mai, WP, Sun, GC, Zhao, ASZ. Synthesis and antimicrobial activity of 9-o substituted palmatine derivatives. Indian J Pharmaceut Sci 2015:196–201. https://doi.org/10.4103/0250-474x.156588.Search in Google Scholar

30. Ren, G, Wang, YX, Li, YH, Song, DQ, Kong, WJ, Jiang, JD. Structure-activity relationship of berberine derivatives for their glucose-lowering activities. Int J Clin Exp Med 2017;10:5054–60.Search in Google Scholar

31. Ge, H, Zhang, Y, Yang, Z, Qiang, K, Chen, C, Sun, L, et al. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands. Bioorg Med Chem 2019;27:2100–11. https://doi.org/10.1016/j.bmc.2019.04.014.Search in Google Scholar

32. Qing, ZX, Yang, P, Tang, Q, Cheng, P, Liu, XB, Zhang, YJ, et al. Isoquinoline alkaloids and their antiviral, antibacterial, and antifungal activities and structure-activity relationship. Curr Org Chem 2017;21:1920–34. https://doi.org/10.2174/1385272821666170207114214.Search in Google Scholar

33. Liu, CS, Zheng, YR, Zhang, YF, Long, XY. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia 2016;109:274–82. https://doi.org/10.1016/j.fitote.2016.02.001.Search in Google Scholar

34. Kamaraj, MC, Mohan Raj, S, Palani Selvam, D, Subashchandrabose, S, Kalaiselvan, A. Haemostatic effects of latex from Croton sparsiflorus Morang, in vitro, in vivo, in silico approaches. Comput Biol Chem 2018;74:157–66. https://doi.org/10.1016/j.compbiolchem.2018.03.025.Search in Google Scholar

Received: 2019-12-10
Accepted: 2020-06-01
Published Online: 2020-07-03
Published in Print: 2021-01-27

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 16.4.2024 from https://www.degruyter.com/document/doi/10.1515/znc-2019-0223/html
Scroll to top button